Acquirer(s)
- C R Bard Inc
Target(s)
- Edwards Lifesciences Corporation
Market definition
The ACCC considered there to be separate Australian markets for the supply of ballon-expanding stents and for the supply of self-expanding stents.Competition analysis
On 8 January 2008, the ACCC formed the view that the proposed acquisition was unlikely to substantially lessen competition in the relevant markets. Factors informing this conclusion included that the merged entity would continue to be constrained by the presence of alternative suppliers of balloon-expanding stents and self-expanding stents.Timeline
| Date | Event |
|---|---|
ACCC commenced review under Merger Review Process Guidelines. Market inquiries commenced. |
|
Closing date for submissions from interested parties. |
|
ACCC announced it would not oppose the proposed acquisition. |